Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
European Journal of Medicinal Chemistry|February 1, 2023
Triazole-fused pyrimidines in target-based anticancer drug discoveryXing-Jie Dai, Lei-Peng Xue, Shi-Kun Ji, et al.Medicinal Research Reviews|February 24, 2026
Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological FunctionsLinyue Bai, Liang Shen, Qianqian Zhang, et al.Journal of Medicinal Chemistry|January 12, 2024
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer TherapyLiang Shen, Bo Wang, Shao-Peng Wang, et al.European Journal of Medicinal Chemistry|March 13, 2023
Discovery of acridine-based LSD1 inhibitors as immune activators targeting LSD1 in gastric cancerHui-Min Liu, Xiao-Peng Xiong, Jiang-Wan Wu, et al.Bioorganic & Medicinal Chemistry|November 28, 2025
Unveiling the power of quinazoline derivatives: a new frontier in targeted cancer therapyHao-Zhe Long, Meng-Jie Fu, Xin-Qian Ji, et al.Fitoterapia|March 12, 2025
Synthesis, cytotoxicity and HQSAR study of amides-fused isosteviol derivatives as potential anti-colorectal cancer agentsCong-Jun Liu, Ling-Yan Guo, Tian-Ci Li, et al.Medicinal Research Reviews|November 28, 2023
LSD1 in drug discovery: From biological function to clinical applicationHui-Min Liu, Ying Zhou, He-Xiang Chen, et al.Theranostics|February 23, 2024
Degraders in epigenetic therapy: PROTACs and beyondXing-Jie Dai, Shi-Kun Ji, Meng-Jie Fu, et al.European Journal of Medicinal Chemistry|August 5, 2023
Novel acridine-based LSD1 inhibitors enhance immune response in gastric cancerXing-Jie Dai, Ying Liu, Ning Wang, et al.Journal of Medicinal Chemistry|October 29, 2025
Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional RegulationXing-Jie Dai, Leipeng Xue, Ying Liu, et al.Pageof 3